(Z)-7-[(1R)-5α-ヒドロキシ-2β-[(E,S)-3-ヒドロキシ-5-フェニル-1-ペンテニル]-3-オキソシクロペンタン-1α-イル]-5-ヘプテン酸

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Danger

(Z)-7-[(1R)-5α-ヒドロキシ-2β-[(E,S)-3-ヒドロキシ-5-フェニル-1-ペンテニル]-3-オキソシクロペンタン-1α-イル]-5-ヘプテン酸 化学特性,用途語,生産方法

• 説明

  17-phenyl trinor Prostaglandin D₂ (17-phenyl trinor PGD₂) is a novel, chemically stable analog of PGD₂ wherein the lower side chain is modified by the addition of a phenyl group at C-17 in place of the last 3 ω-chain carbon atoms. This modification has not been reported in a D-type prostaglandin. However, in the PGE and PGF series, the analogous modification leads to a stable, somewhat more potent agonist which embodies the same biological activities as the parent prostaglandins.

• 使用

  17-phenyl trinor Prostaglandin D2 (17-phenyl trinor PGD2) is a novel, chemically stable analog of PGD2 wherein the lower side chain is modified by the addition of a phenyl group at C-17 in place of the last 3 ω-chain carbon atoms. This modification has not been reported in a D-type prostaglandin. However, in the PGE and PGF series, the analogous modification leads to a stable, somewhat more potent agonist which embodies the same biological activities as the parent prostaglandins.[Cayman Chemical]

• 定義

  ChEBI: A prostanoid that is 18,19,20-trinor-prostaglandin D2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group.

(Z)-7-[(1R)-5α-ヒドロキシ-2β-[(E,S)-3-ヒドロキシ-5-フェニル-1-ペンテニル]-3-オキソシクロペンタン-1α-イル]-5-ヘプテン酸 生産企業

Global(6)Suppliers